Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Topspin Biotech Fund Leads $74M Series B In Pharma Startup
Venture Capital

Topspin Biotech Fund Leads $74M Series B In Pharma Startup

by prnewswire.com posted 1year ago 391 views
<p>PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, today announced the completion of a&nbsp;$74 million&nbsp;Series B financing round. &nbsp;This financing was led by Topspin Biotech Fund and a group of investors with Euclidean Capital, with participation from existing investors InterWest Partners, OrbiMed Advisors, and Osage University Partners.</p>